The Role of DPP-4 Inhibitor/Metformin Fixed-Dose Combinations in Treating Type 2 Diabetes Mellitus  

Oleh:

Wai, Daniel Chun-Hang ; Tai, E-Shyong

Jenis: Article from Bulletin/Magazine - ilmiah internasional
Dalam koleksi: Medical Progress vol. 36 no. 08 (Aug. 2009), page 389-392.
Topik: Dipeptidyl peptidase-4 (DPP-4); metformin

Ketersediaan

Perpustakaan FK Nomor Panggil: M36.K.2009.02 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Diabetes mellitus (DM) is a global epidemic, and most patients in Asia have poor glycaemic control. Dipeptidyl peptidase-4 (DPP-4) inhibitors are new additions to the antidiabetic drug arsenal. More recently, these compounds have become available as fixed-dose combinations with metformin. in this paper, we examine the clinical effects of these compounds and discuss their role in the management of type 2 DM.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali